ARS Pharmaceuticals Inc’s recent filing unveils that its Director Shawver Laura acquired Company’s shares for reported $0.56 million on Jan 06 ’25. In the deal valued at $11.10 per share,50,000 shares were bought.
Then, Tanimoto Sarina sold 100,000 shares, generating $1,167,100 in total proceeds. Upon selling the shares at $11.67, the CHIEF MEDICAL OFFICER now owns 1,098,499 shares.
Before that, Lowenthal Richard E sold 100,000 shares. ARS Pharmaceuticals Inc shares valued at $1,167,100 were divested by the PRESIDENT AND CEO at a price of $11.67 per share. As a result of the transaction, Lowenthal Richard E now holds 1,098,499 shares, worth roughly $12.17 million.
Cantor Fitzgerald initiated its ARS Pharmaceuticals Inc [SPRY] rating to an Overweight in a research note published recently. A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in mid August from “an Outperform” to “a Strong buy”. Leerink Partners also remained covering SPRY and reiterated its “an Outperform” recommendation on August 12, 2024. Raymond James started covering the stock on July 25, 2024. It rated SPRY as “an Outperform”.
Price Performance Review of SPRY
On Monday, ARS Pharmaceuticals Inc [NASDAQ:SPRY] saw its stock fall -0.98% to $11.08. Over the last five days, the stock has gained 2.69%. ARS Pharmaceuticals Inc shares have risen nearly 5.02% since the year began. Nevertheless, the stocks have risen 96.45% over the past one year. While a 52-week high of $18.51 was reached on 01/06/25, a 52-week low of $5.19 was recorded on 01/02/25. SMA at 50 days reached $13.48, while 200 days put it at $11.53.
Levels Of Support And Resistance For SPRY Stock
The 24-hour chart illustrates a support level at 10.65, which if violated will result in even more drops to 10.22. On the upside, there is a resistance level at 11.55. A further resistance level may holdings at 12.01. The Relative Strength Index (RSI) on the 14-day chart is 38.47, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 59.82%. Stochastics %K at 33.40% indicates the stock is a holding.
How much short interest is there in ARS Pharmaceuticals Inc?
A steep rise in short interest was recorded in ARS Pharmaceuticals Inc stocks on 2024-12-13, dropping by -1.2 million shares to a total of 12.66 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 13.85 million shares. There was a decline of -9.44%, which implies that there is a negative sentiment for the stock.
